Blepharophimosis Syndrome: The Eyelid Finding That Predicts Ovarian Failure

A single gene, expressed in two seemingly unrelated organs, can link a childhood eyelid finding to a woman’s fertility decades later.

Blepharophimosis syndrome (BPES) is a congenital eyelid malformation complex, and in one of its two forms, it is also a marker of premature ovarian insufficiency.

The eyelid findings alone are distinctive enough to recognize on sight — small palpebral fissures, ptosis, and skin folds running the “wrong way” at the inner corner of the eye.

What is not visible on inspection is which genetic subtype a given patient has, and that distinction carries real implications well beyond the eyelids.

Missing the connection to ovarian function in Type I disease means missing a window for fertility counseling that matters enormously to the patient later in life.

Recognizing the eyelid phenotype and understanding both surgical management and the systemic implications is essential for anyone evaluating a child with this presentation.

What Is Blepharophimosis Syndrome?

Blepharophimosis syndrome (BPES), also called blepharophimosis-ptosis-epicanthus inversus syndrome, is a congenital eyelid malformation caused by mutation of the FOXL2 gene.

Its four defining eyelid features give the syndrome its full name:

Blepharophimosis — abnormally short horizontal palpebral fissures
Ptosis — typically bilateral and moderate to severe, with poor levator function
Epicanthus inversus — a skin fold running from the lower eyelid upward, the reverse of the more common epicanthal fold direction
Telecanthus — increased distance between the inner corners of the eyes, with normal interpupillary distance

BPES is further divided into two genetically and clinically distinct types, a distinction that carries real systemic significance.

Epidemiology

BPES is a rare but well-characterized genetic syndrome.

Inheritance is autosomal dominant with high penetrance, though the severity can vary between affected family members
Type I BPES includes premature ovarian insufficiency in affected females and is transmitted only through affected males, since affected females are typically infertile
Type II BPES is limited to the eyelid findings, without associated ovarian dysfunction, and can be transmitted by either sex
Roughly half of cases arise from a new (de novo) mutation rather than being inherited from an affected parent

Because Type I and Type II are clinically indistinguishable by eyelid appearance alone, genetic characterization is what actually determines whether a family needs reproductive counseling.

Pathophysiology

BPES results from mutation or deletion of the FOXL2 gene, which has dual roles in development.

FOXL2 is essential for normal eyelid development, and its disruption produces the characteristic short fissures, ptosis, and epicanthal fold pattern
FOXL2 is also essential for normal ovarian follicle maintenance and granulosa cell function
Mutations that disrupt both functions produce Type I disease, with both the eyelid phenotype and premature ovarian insufficiency
Mutations or deletion patterns that spare ovarian function produce the eyelid-only Type II phenotype
The specific type and location of the FOXL2 mutation is what largely determines which clinical type results

This dual role of a single gene in two apparently unrelated tissues is exactly why an eyelid finding in this syndrome can carry implications for reproductive health.

Risk Factors

Genetic Risk Factors

A parent with BPES, given autosomal dominant inheritance with high penetrance
Family history of premature ovarian insufficiency in female relatives, which should raise suspicion for Type I disease specifically

Other Considerations

Roughly half of cases occur without a family history, from a de novo mutation
No environmental or acquired risk factor has been established — this is a purely genetic condition

A family history of early menopause or infertility in female relatives is a specific detail worth asking about directly, since it points toward Type I disease before genetic testing results are even available.

Clinical Presentation

Symptoms

Small-appearing eyes noticed from infancy, often the presenting concern for parents
Visual field obstruction from ptosis, sometimes severe enough to risk amblyopia if untreated
Compensatory chin-up head posture or brow elevation in children working to see under ptotic lids
In Type I disease, secondary amenorrhea or infertility presenting later in affected females

Examination Findings

Symmetrically short horizontal palpebral fissures, giving a small-eyed appearance
Bilateral ptosis with poor levator function, often more severe than typical congenital ptosis
Epicanthus inversus — a distinct skin fold arising from the lower lid and running upward, unlike the more common epicanthal fold pattern
Telecanthus with a flattened nasal bridge appearance, though true interpupillary distance is normal
A poorly developed or absent upper eyelid crease, reflecting the severity of the levator abnormality

The combination of all four features together — not any single one alone — is what confirms BPES rather than an isolated ptosis or epicanthal fold.

Diagnostic Evaluation

Clinical Examination

Diagnosis is primarily clinical, based on the characteristic combination of blepharophimosis, ptosis, epicanthus inversus, and telecanthus
MRD1 and levator function measurement to guide surgical planning for the ptosis component

Genetic Testing

FOXL2 mutation analysis to confirm the diagnosis and, where possible, distinguish Type I from Type II disease
Genetic counseling for the family regarding inheritance pattern and reproductive implications

Systemic Evaluation (Females)

Referral to gynecology/reproductive endocrinology for baseline assessment and long-term monitoring of ovarian function in females, particularly when Type I disease is confirmed or suspected
Ongoing surveillance for premature ovarian insufficiency through adolescence and early adulthood

Every female patient with BPES deserves a conversation about reproductive health monitoring — this is not an optional referral, given how consequential missed premature ovarian insufficiency can be.

Differential Diagnosis

Conditions that can resemble BPES include:

Isolated congenital ptosis — without the associated epicanthus inversus and telecanthus of BPES
Common epicanthal folds — run in the opposite direction from lower to upper lid medially, and are not associated with short fissures or ptosis
Ohdo syndrome and other blepharophimosis-associated syndromes — additional systemic or developmental features beyond the isolated eyelid and ovarian findings of BPES
Waardenburg syndrome — telecanthus can overlap, but pigmentary and hearing abnormalities distinguish it from BPES

The specific combination of all four eyelid findings, without other syndromic features, is what usually confirms BPES rather than these related conditions.

Management

Surgical Correction

Medial canthoplasty to correct epicanthus inversus and telecanthus, typically performed first
Ptosis repair, usually with frontalis sling suspension given the characteristically poor levator function in BPES, performed as a staged second procedure
Careful surgical sequencing and timing balances amblyopia risk from visual axis obstruction against surgical risk in a young child

Amblyopia Prevention

Close monitoring for amblyopia given the visual axis obstruction from ptosis
Prompt surgical intervention when ptosis significantly obstructs vision, rather than deferring purely for cosmetic timing

Systemic Management (Type I)

Coordinated care with gynecology/reproductive endocrinology for females with confirmed or suspected Type I disease
Fertility counseling and monitoring as the patient approaches reproductive age

Surgical management addresses the eyelids, but genetic counseling and, in Type I disease, gynecologic follow-up are what actually address the syndrome’s full scope.

Prognosis

Ocular prognosis after appropriate surgical management is generally good.

Staged medial canthoplasty and ptosis repair typically achieve good functional and cosmetic results
Amblyopia risk is manageable with timely surgical intervention and appropriate follow-up
Type I disease carries a separate, non-ocular prognosis tied to ovarian function, with most affected females experiencing premature ovarian insufficiency

The eyelid surgery outcome and the syndrome’s overall prognosis are really two separate conversations — a successful ptosis repair says nothing about the reproductive counseling a Type I patient still needs.

References

Crisponi L, Deiana M, Loi A, et al. The putative forkhead transcription factor FOXL2 is mutated in blepharophimosis/ptosis/epicanthus inversus syndrome. Nature Genetics. 2001.
Beysen D, De Paepe A, De Baere E. FOXL2 mutations and genomic rearrangements in BPES. Human Mutation. 2009.
Blepharophimosis, Ptosis, and Epicanthus Inversus Syndrome. StatPearls, NCBI Bookshelf.
Blepharophimosis Syndrome. EyeWiki, American Academy of Ophthalmology.
Verdin H, De Baere E. FOXL2 impairment in human disease. Hormone Research in Paediatrics. 2012.